CBT | CHOP Research Institute
 

CBT

1 - 1 of 1

FDA Approval, Mitochondrial Dysfunction, Pediatric Headaches

Published on
Aug 18, 2023
in Cornerstone Blog
In the News: FDA Approval, Mitochondrial Dysfunction
The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.
1 - 1 of 1